274.97 million. Loss attributable to non-controlling interests was Baht 0.32 million. DCORP loss remains Baht 274.65 million. Compared with the consolidated financial statements for the same period of the

of 9 Non-controlling interests - Net Tangible Assets (NTA) 367.78 Therefore, in the execution of the transaction on disposal of assets, the Company is required to comply with the Public Limited

as of 11 December 2019 2 /NTA (Net Tangible Assets) is equal to total assets less intangible assets, total liabilities and non-controlling interests 3/ Profits during the last 12 months (only a portion

Total shareholders’ equity 22,342.4 30,004.5 (7,662.1) Remark (1) Comprised of discount on changes in shareholding in subsidiaries and non-controlling interests of the subsidiaries As of 31 March 2020

expenses (reversal) 0.0 0.0 0.0 - - Profit before income tax expenses 139.0 183.0 138.7 -0.2% -24.2% Tax expenses (reversal) 7.5 42.4 20.6 +174.4% -51.5% Profit (loss) attributable to non- controlling

shareholders and directors of Modern Pharma Company Limited are not Executive Committee and shareholders including those with controlling power in the company. Therefore, it is not considered a connected

debts 7,515,428 801,233 Interests without controlling power 573,262 11 Net tangible asset (NTA) 2,765,616 660,210 Net profit 620,824 208,793 Proportion 100% Enclosure 1 5 information in the consolidated

(expense) 203 214 271 34% 27% 271 - Finance cost (1,217) (1,171) (1,201) -1.3% 2.6% (1,564) (363) Income tax (1,523) (1,303) (1,397) -8.3% 7.2% (1,335) 62 Non-controlling interest (1.0) (0.8) (1) -23% -7.4

120 196 44% 63% 731 986 35% Finance cost 1,358 1,414 1,366 0.6% -3.4% 5,917 5,626 -4.9% Income tax 1,128 1,399 1,522 35% 8.8% 5,089 5,970 17% Non-controlling interest -1 -0.6 -1 12% 25% -3 -2 -20% Net

-50 % Finance cost 1,366 1,294 1,294 -5.3 % —% 5,626 5,231 -7.0 % Income tax 1,522 1,410 1,747 15 % 24 % 5,970 6,168 3.3 % Non-controlling interest -0.7 -0.7 -0.7 —% 5.1 % -2 -3 13 % Net profit for the